ResMed (RMD)
ResMed on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus.
11.9M
Short interest
settlement 2026-10-15
12.3
Days to cover
+2.4 days vs prior
78.5%
Short share of volume
2026-11-02
1
Fails to deliver
settlement 2026-10-13
Thu 28 Jan
Next earnings
estimated date
-$5.4M
Insider flow, 90 days
0 buys, 6 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in RMD is 11,920,328 shares, down 2,283,579 shares over the last month. Over the last 48 readings it ranged from 7,312,478 shares (15 November 2024) to 15,676,616 shares (31 July 2026). At the reported average volume of 967K shares a day that is 12.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rmd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 11,920,328 | -6.8% | 966,537 | 12.33 |
| 2026-09-30 | 12,783,009 | -10.0% | 1,294,339 | 9.88 |
| 2026-09-15 | 14,203,907 | +8.7% | 1,209,593 | 11.74 |
| 2026-08-31 | 13,073,165 | +2.2% | 1,462,283 | 8.94 |
| 2026-08-14 | 12,794,915 | -18.4% | 1,727,103 | 7.41 |
| 2026-07-31 | 15,676,616 | +15.8% | 1,104,429 | 14.19 |
| 2026-07-15 | 13,541,103 | -10.3% | 1,726,912 | 7.84 |
| 2026-06-30 | 15,104,487 | +16.9% | 1,778,242 | 8.49 |
| 2026-06-15 | 12,915,210 | +8.7% | 1,431,442 | 9.02 |
| 2026-05-29 | 11,881,847 | -12.5% | 1,618,671 | 7.34 |
| 2026-05-15 | 13,573,617 | +10.4% | 1,612,973 | 8.42 |
| 2026-04-30 | 12,298,239 | +7.0% | 1,195,806 | 10.28 |
| 2026-04-15 | 11,494,456 | -3.3% | 906,361 | 12.68 |
| 2026-03-31 | 11,889,620 | +0.4% | 1,067,023 | 11.14 |
| 2026-03-13 | 11,845,253 | +0.1% | 1,048,993 | 11.29 |
| 2026-02-27 | 11,837,993 | +17.2% | 965,467 | 12.26 |
| 2026-02-13 | 10,098,338 | -9.2% | 1,462,658 | 6.90 |
| 2026-01-30 | 11,124,518 | -2.7% | 1,173,742 | 9.48 |
| 2026-01-15 | 11,433,978 | -2.0% | 870,817 | 13.13 |
| 2025-12-31 | 11,672,492 | +10.6% | 945,555 | 12.34 |
| 2025-12-15 | 10,557,741 | +1.4% | 889,744 | 11.87 |
| 2025-11-28 | 10,416,904 | -2.2% | 937,247 | 11.11 |
| 2025-11-14 | 10,647,780 | +9.9% | 1,386,837 | 7.68 |
| 2025-10-31 | 9,690,007 | +8.1% | 1,282,242 | 7.56 |
| 2025-10-15 | 8,964,374 | +1.8% | 833,890 | 10.75 |
| 2025-09-30 | 8,806,208 | +1.8% | 870,896 | 10.11 |
| 2025-09-15 | 8,649,291 | +1.6% | 1,028,349 | 8.41 |
| 2025-08-29 | 8,510,839 | -4.8% | 941,115 | 9.04 |
| 2025-08-15 | 8,937,310 | -0.9% | 1,153,943 | 7.75 |
| 2025-07-31 | 9,019,375 | -3.8% | 1,134,081 | 7.95 |
| 2025-07-15 | 9,377,215 | -7.4% | 716,303 | 13.09 |
| 2025-06-30 | 10,127,096 | +2.0% | 902,177 | 11.23 |
| 2025-06-13 | 9,929,357 | -6.2% | 673,901 | 14.73 |
| 2025-05-30 | 10,587,778 | -3.2% | 831,648 | 12.73 |
| 2025-05-15 | 10,934,667 | +16.0% | 976,809 | 11.19 |
| 2025-04-30 | 9,426,073 | +3.5% | 1,265,721 | 7.45 |
| 2025-04-15 | 9,108,017 | +2.3% | 1,576,260 | 5.78 |
| 2025-03-31 | 8,899,359 | +2.0% | 780,226 | 11.41 |
| 2025-03-14 | 8,726,934 | -0.0% | 1,083,181 | 8.06 |
| 2025-02-28 | 8,730,591 | -10.1% | 939,085 | 9.30 |
| 2025-02-14 | 9,709,488 | +17.0% | 1,000,148 | 9.71 |
| 2025-01-31 | 8,300,270 | +3.2% | 1,122,435 | 7.39 |
| 2025-01-15 | 8,040,958 | +1.7% | 778,829 | 10.32 |
| 2024-12-31 | 7,908,131 | +1.3% | 843,810 | 9.37 |
| 2024-12-13 | 7,806,232 | +3.6% | 633,657 | 12.32 |
| 2024-11-29 | 7,537,090 | +3.1% | 706,523 | 10.67 |
| 2024-11-15 | 7,312,478 | -7.4% | 984,859 | 7.42 |
| 2024-10-31 | 7,893,566 | -8.9% | 1,328,796 | 5.94 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of RMD volume is 78.5%, up 14.2 points over the last five sessions. Over the last 30 readings it ranged from 39.6% (22 October 2026) to 82.8% (19 October 2026). The latest reading sits at the top of that range. The latest reading is 9.4 points above the 30-session average of 69.1%, on 587K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 461K | 587K | 78.5% | 56 |
| 2026-10-30 | 1.1M | 1.5M | 76.5% | 1,390 |
| 2026-10-29 | 368K | 721K | 51.0% | 20 |
| 2026-10-28 | 217K | 283K | 76.8% | 1,338 |
| 2026-10-27 | 283K | 408K | 69.4% | 231 |
| 2026-10-26 | 212K | 330K | 64.3% | 521 |
| 2026-10-23 | 226K | 332K | 68.1% | 55 |
| 2026-10-22 | 257K | 649K | 39.6% | 0 |
| 2026-10-21 | 236K | 305K | 77.5% | 355 |
| 2026-10-20 | 420K | 553K | 75.9% | 2 |
| 2026-10-19 | 246K | 297K | 82.8% | 3 |
| 2026-10-16 | 512K | 630K | 81.3% | 23 |
| 2026-10-15 | 359K | 475K | 75.5% | 304 |
| 2026-10-14 | 215K | 342K | 62.8% | 1,620 |
| 2026-10-13 | 269K | 338K | 79.6% | 0 |
| 2026-10-12 | 399K | 491K | 81.2% | 480 |
| 2026-10-09 | 241K | 352K | 68.5% | 0 |
| 2026-10-08 | 141K | 224K | 62.7% | 0 |
| 2026-10-07 | 252K | 391K | 64.3% | 0 |
| 2026-10-06 | 228K | 311K | 73.5% | 1,099 |
| 2026-10-05 | 237K | 362K | 65.3% | 9,305 |
| 2026-10-02 | 256K | 388K | 65.9% | 0 |
| 2026-10-01 | 263K | 366K | 71.9% | 1 |
| 2026-09-30 | 390K | 585K | 66.7% | 0 |
| 2026-09-29 | 271K | 407K | 66.6% | 163 |
| 2026-09-28 | 214K | 320K | 66.9% | 45 |
| 2026-09-25 | 140K | 205K | 68.6% | 0 |
| 2026-09-24 | 219K | 314K | 69.5% | 30 |
| 2026-09-23 | 373K | 566K | 65.8% | 22 |
| 2026-09-22 | 165K | 297K | 55.5% | 132 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in RMD is 1 share, down 85 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (13 October 2026) to 84,382 shares (15 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 1 | $234.60 | $235 |
| 2026-10-09 | 86 | $226.73 | $19K |
| 2026-10-06 | 21 | $222.86 | $5K |
| 2026-09-29 | 3,652 | $222.10 | $811K |
| 2026-09-28 | 2,205 | $222.00 | $490K |
| 2026-09-25 | 87 | $221.89 | $19K |
| 2026-09-24 | 245 | $222.30 | $54K |
| 2026-09-22 | 16,067 | $223.61 | $3.6M |
| 2026-09-18 | 1,801 | $228.42 | $411K |
| 2026-09-15 | 84,382 | $222.99 | $18.8M |
| 2026-09-14 | 917 | $218.27 | $200K |
| 2026-09-08 | 174 | $228.35 | $40K |
| 2026-09-03 | 15,143 | $230.87 | $3.5M |
| 2026-09-01 | 102 | $240.10 | $24K |
| 2026-08-31 | 9,869 | $240.33 | $2.4M |
| 2026-08-27 | 69 | $235.69 | $16K |
| 2026-08-24 | 200 | $231.52 | $46K |
| 2026-08-20 | 298 | $230.65 | $69K |
| 2026-08-18 | 38 | $220.37 | $8K |
| 2026-08-12 | 22 | $224.84 | $5K |
| 2026-08-11 | 70 | $220.05 | $15K |
| 2026-08-10 | 21,011 | $211.94 | $4.5M |
| 2026-07-22 | 43,590 | $195.80 | $8.5M |
| 2026-07-21 | 44,905 | $198.61 | $8.9M |
| 2026-07-10 | 60 | $208.45 | $13K |
| 2026-07-09 | 207 | $205.84 | $43K |
| 2026-07-08 | 274 | $219.75 | $60K |
| 2026-07-07 | 210 | $218.40 | $46K |
| 2026-07-06 | 2,170 | $209.63 | $455K |
| 2026-07-01 | 5,407 | $194.88 | $1.1M |
Insider trades
SEC Form 4, newest first. JSONInsiders at RMD reported 6 open-market sells worth $5.4M in the last 90 days and no open-market buys. Latest filing: Rider Michael J (Global General Counsel) on 2026-10-23.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-23 | Rider Michael J | Global General Counsel | Sell | 400 | $255.00 | $102K | 12K |
| 2026-10-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $226.33 | $1.1M | 480K |
| 2026-10-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 485K |
| 2026-09-08 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $222.44 | $1.1M | 466K |
| 2026-09-08 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-09-02 | FARRELL PETER C | Director | Sell | 970 | $234.73 | $228K | 52K |
| 2026-08-14 | Farrell Michael J. | Chairman and CEO | Grant | 14K | $0.00 | $0 | 480K |
| 2026-08-14 | Bloomer Aaron | Chief Financial Officer | Grant | 9K | $0.00 | $0 | 9K |
| 2026-08-14 | Rider Michael J | Global General Counsel | Grant | 3K | $0.00 | $0 | 13K |
| 2026-08-14 | Leong Justin | Chief Product Officer | Grant | 6K | $0.00 | $0 | 35K |
| 2026-08-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $205.69 | $1.0M | 466K |
| 2026-08-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-08-05 | FARRELL PETER C | Director | Sell | 8K | $225.00 | $1.8M | 53K |
| 2026-07-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $218.55 | $1.1M | 466K |
| 2026-07-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-06-08 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $193.96 | $968K | 466K |
| 2026-06-08 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-06-01 | Rider Michael J | Global General Counsel | Tax withholding | 269 | $190.57 | $51K | 9K |
| 2026-06-01 | Rider Michael J | Global General Counsel | Tax withholding | 269 | $190.57 | $51K | 9K |
| 2026-05-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $207.82 | $1.0M | 466K |
| 2026-05-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-04-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $225.50 | $1.1M | 466K |
| 2026-04-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-04-01 | FARRELL PETER C | Director | Sell | 2K | $225.00 | $450K | 61K |
| 2026-04-01 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $224.31 | $224K | 83K |
| 2026-03-09 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $251.03 | $1.3M | 466K |
| 2026-03-09 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-03-04 | FARRELL PETER C | Director | Sell | 2K | $260.22 | $520K | 63K |
| 2026-03-02 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $254.30 | $254K | 84K |
| 2026-02-09 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $273.78 | $1.4M | 466K |
| 2026-02-09 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-02-04 | Rider Michael J | Global General Counsel | Sell | 50 | $260.00 | $13K | 10K |
| 2026-02-04 | FARRELL PETER C | Director | Sell | 2K | $251.31 | $503K | 65K |
| 2026-02-02 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $257.03 | $257K | 85K |
| 2026-01-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $248.46 | $1.2M | 466K |
| 2026-01-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2026-01-07 | FARRELL PETER C | Director | Sell | 2K | $248.83 | $498K | 67K |
| 2026-01-02 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $241.75 | $242K | 86K |
| 2026-01-02 | Rider Michael J | Global General Counsel | Sell | 50 | $241.75 | $12K | 10K |
| 2025-12-08 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $251.41 | $1.3M | 466K |
| 2025-12-08 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 5K | $146.34 | $730K | 471K |
| 2025-12-03 | FARRELL PETER C | Director | Sell | 2K | $251.47 | $503K | 69K |
| 2025-12-01 | Rider Michael J | Global General Counsel | Sell | 50 | $244.16 | $12K | 10K |
| 2025-12-01 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $244.16 | $244K | 87K |
| 2025-11-25 | De Witte Jan | Director | Sell | 2K | $255.00 | $524K | 4K |
| 2025-11-20 | Tan Desney | Director | Grant | 1K | $0.00 | $0 | 6K |
| 2025-11-20 | TAYLOR RONALD R | Director | Grant | 1K | $0.00 | $0 | 25K |
| 2025-11-20 | Sandercock Brett | Chief Financial Officer | Grant | 3K | $0.00 | $0 | 88K |
| 2025-11-20 | Mowad-Nassar Nicole | Director | Grant | 536 | $0.00 | $0 | 777 |
| 2025-11-20 | Leong Justin | Chief Product Officer | Grant | 2K | $0.00 | $0 | 29K |
| 2025-11-20 | Hernandez John | Director | Grant | 1K | $0.00 | $0 | 5K |
| 2025-11-20 | Gill Harjit | Director | Grant | 1K | $0.00 | $0 | 11K |
| 2025-11-20 | Farrell Michael J. | Chairman and CEO | Tax withholding | 7K | $0.00 | $0 | 466K |
| 2025-11-20 | Farrell Michael J. | Chairman and CEO | Grant | 14K | $0.00 | $0 | 474K |
| 2025-11-20 | FARRELL PETER C | Director | Grant | 536 | $0.00 | $0 | 71K |
| 2025-11-20 | Drexler Karen | Director | Grant | 1K | $0.00 | $0 | 11K |
| 2025-11-20 | DelOrefice Christopher | Director | Grant | 1K | $0.00 | $0 | 2K |
| 2025-11-20 | De Witte Jan | Director | Grant | 1K | $0.00 | $0 | 6K |
| 2025-11-20 | Burt Carol | Director | Grant | 1K | $0.00 | $0 | 2K |
| 2025-11-14 | FARRELL PETER C | Director | Tax withholding | 7K | $244.46 | $1.8M | 70K |
| 2025-11-14 | FARRELL PETER C | Director | Exercise or conversion | 11K | $101.64 | $1.2M | 78K |
| 2025-11-12 | FARRELL PETER C | Director | Sell | 2K | $252.05 | $504K | 66K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 715 | $250.10 | $179K | 10K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 174 | $250.10 | $43K | 11K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 135 | $250.10 | $34K | 11K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 501 | $250.10 | $125K | 10K |
| 2025-11-11 | De Witte Jan | Director | Tax withholding | 76 | $250.10 | $19K | 5K |
| 2025-11-11 | Farrell Michael J. | Chairman and CEO | Tax withholding | 2K | $250.10 | $552K | 460K |
| 2025-11-11 | Farrell Michael J. | Chairman and CEO | Tax withholding | 2K | $250.10 | $558K | 466K |
| 2025-11-11 | Farrell Michael J. | Chairman and CEO | Tax withholding | 3K | $250.10 | $865K | 462K |
| 2025-11-11 | FARRELL PETER C | Director | Tax withholding | 163 | $250.10 | $41K | 68K |
| 2025-11-11 | Gill Harjit | Director | Tax withholding | 38 | $250.10 | $10K | 10K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 501 | $250.10 | $125K | 10K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 715 | $250.10 | $179K | 10K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 174 | $250.10 | $43K | 11K |
| 2025-11-11 | Rider Michael J | Global General Counsel | Tax withholding | 135 | $250.10 | $34K | 11K |
| 2025-11-11 | Farrell Michael J. | Chairman and CEO | Tax withholding | 2K | $250.10 | $552K | 460K |
| 2025-11-11 | Farrell Michael J. | Chairman and CEO | Tax withholding | 3K | $250.10 | $865K | 462K |
| 2025-11-11 | Farrell Michael J. | Chairman and CEO | Tax withholding | 2K | $250.10 | $558K | 466K |
| 2025-11-11 | FARRELL PETER C | Director | Tax withholding | 163 | $250.10 | $41K | 68K |
| 2025-11-11 | De Witte Jan | Director | Tax withholding | 76 | $250.10 | $19K | 5K |
| 2025-11-11 | De Witte Jan | Director | Sell | 487 | $250.25 | $122K | 5K |
| 2025-11-11 | Gill Harjit | Director | Tax withholding | 38 | $250.10 | $10K | 10K |
| 2025-11-07 | Farrell Michael J. | Chairman and CEO | Sell | 8K | $249.75 | $2.0M | 468K |
| 2025-11-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 7K | $101.64 | $714K | 476K |
| 2025-11-07 | Farrell Michael J. | Chairman and CEO | Exercise or conversion | 983 | $101.64 | $100K | 469K |
| 2025-11-03 | Sandercock Brett | Chief Financial Officer | Sell | 3K | $247.54 | $743K | 86K |
| 2025-11-03 | Sandercock Brett | Chief Financial Officer | Exercise or conversion | 2K | $101.64 | $203K | 89K |
| 2025-10-07 | Farrell Michael J. | Chief Executive Officer | Sell | 8K | $282.85 | $2.3M | 468K |
| 2025-10-07 | Farrell Michael J. | Chief Executive Officer | Exercise or conversion | 8K | $101.64 | $814K | 476K |
| 2025-10-01 | Rider Michael J | Global General Counsel | Sell | 100 | $274.36 | $27K | 11K |
| 2025-10-01 | Sandercock Brett | Chief Financial Officer | Sell | 3K | $274.36 | $823K | 87K |
| 2025-10-01 | Sandercock Brett | Chief Financial Officer | Exercise or conversion | 2K | $101.64 | $203K | 90K |
| 2025-09-08 | Farrell Michael J. | Chief Executive Officer | Sell | 8K | $278.14 | $2.2M | 468K |
| 2025-09-08 | Farrell Michael J. | Chief Executive Officer | Exercise or conversion | 8K | $101.64 | $814K | 476K |
| 2025-09-02 | Sandercock Brett | Chief Financial Officer | Sell | 3K | $270.77 | $812K | 88K |
| 2025-09-02 | Sandercock Brett | Chief Financial Officer | Exercise or conversion | 2K | $101.64 | $203K | 91K |
| 2025-09-02 | Mowad-Nassar Nicole | Director | Grant | 241 | $0.00 | $0 | 241 |
| 2025-08-18 | Hernandez John | Director | Sell | 3K | $287.10 | $739K | 4K |
| 2025-08-18 | Hernandez John | Director | Exercise or conversion | 3K | $148.90 | $383K | 7K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON35 Form 144 notices on file for RMD worth $26.5M at the prices reported; 4 in the last 90 days worth $3.4M. Latest: Rider Michael J filed on 2026-10-23 to sell 400 shares ($102K) from 2026-10-23.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-10-23 | Rider Michael JOfficer | 400 | $102K | 0.000% | 2026-10-23 | Fidelity Brokerage Services LLC |
| 2026-10-07 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-10-07 | Fidelity Brokerage Services LLC |
| 2026-09-08 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-09-08 | Fidelity Brokerage Services LLC |
| 2026-08-07 | Farrell Michael J.Officer, Director | 5K | $1.0M | 0.003% | 2026-08-07 | Fidelity Brokerage Services LLC |
| 2026-07-07 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-07-07 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Farrell Michael J.Officer, Director | 5K | $968K | 0.003% | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2026-05-27 | Sandercock BrettFormer Officer | 8K | $1.7M | 0.006% | 2026-05-27 | Fidelity Brokerage Services LLC |
| 2026-05-07 | Farrell Michael J.Officer, Director | 5K | $1.0M | 0.003% | 2026-05-07 | Fidelity Brokerage Services LLC |
| 2026-04-07 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-04-07 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Sandercock BrettOfficer | 1K | $224K | 0.001% | 2026-04-01 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Peter C FarrellDirector | 2K | $450K | 0.004% | 2026-04-01 | Merrill Lynch |
| 2026-03-09 | Farrell Michael J.Officer, Director | 5K | $1.2M | 0.003% | 2026-03-09 | Fidelity Brokerage Services LLC |
| 2026-03-04 | Peter C FarrellDirector | 2K | $520K | 0.004% | 2026-03-04 | Merrill Lynch |
| 2026-03-02 | Sandercock BrettOfficer | 1K | $254K | 0.001% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-02-09 | Farrell Michael J.Officer, Director | 5K | $1.4M | 0.003% | 2026-02-09 | Fidelity Brokerage Services LLC |
| 2026-02-04 | Rider Michael JOfficer | 50 | $13K | 0.000% | 2026-02-04 | Fidelity Brokerage Services LLC |
| 2026-02-04 | Peter C FarrellDirector | 2K | $503K | 0.004% | 2026-02-04 | Merrill Lynch |
| 2026-02-02 | Sandercock BrettOfficer | 1K | $257K | 0.001% | 2026-02-02 | Fidelity Brokerage Services LLC |
| 2026-01-07 | Farrell Michael J.Officer, Director | 5K | $1.2M | 0.003% | 2026-01-07 | Fidelity Brokerage Services LLC |
| 2026-01-07 | Peter C FarrellDirector | 2K | $498K | 0.004% | 2026-01-07 | Merrill Lynch |
| 2026-01-02 | Sandercock BrettOfficer | 1K | $242K | 0.001% | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2026-01-02 | Rider Michael JOfficer | 50 | $12K | 0.000% | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2025-12-08 | Farrell Michael J.Officer, Director | 5K | $1.3M | 0.003% | 2025-12-08 | Fidelity Brokerage Services LLC |
| 2025-12-03 | Peter C FarrellDirector | 2K | $503K | 0.004% | 2025-12-03 | Merrill Lynch |
| 2025-12-01 | Sandercock BrettOfficer | 1K | $244K | 0.001% | 2025-12-01 | Fidelity Brokerage Services LLC |
| 2025-12-01 | Rider Michael JOfficer | 50 | $12K | 0.000% | 2025-12-01 | Fidelity Brokerage Services LLC |
| 2025-11-25 | De Witte JanDirector | 2K | $524K | 0.001% | 2025-11-25 | Fidelity Brokerage Services LLC |
| 2025-11-12 | Peter C FarrellDirector | 2K | $504K | 0.004% | 2025-11-12 | Merrill Lynch |
| 2025-11-12 | De Witte JanDirector | 487 | $122K | 0.000% | 2025-11-11 | Fidelity Brokerage Services LLC |
| 2025-11-07 | Farrell Michael J.Officer, Director | 8K | $2.0M | 0.005% | 2025-11-07 | Fidelity Brokerage Services LLC |
| 2025-11-03 | Sandercock BrettOfficer | 3K | $743K | 0.002% | 2025-11-03 | Fidelity Brokerage Services LLC |
| 2025-10-07 | Ghoshal KaushikFormer Officer | 5K | $1.4M | 0.003% | 2025-10-07 | Fidelity Brokerage Services LLC |
| 2025-10-07 | Farrell Michael J.Officer, Director | 8K | $2.3M | 0.005% | 2025-10-07 | Fidelity Brokerage Services LLC |
| 2025-10-01 | Rider Michael JOfficer | 100 | $27K | 0.000% | 2025-10-01 | Fidelity Brokerage Services LLC |
| 2025-10-01 | Sandercock BrettOfficer | 3K | $823K | 0.002% | 2025-10-01 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON3 holders report 5% or more of RMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 8.2% of the class (11,961,706 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-07 | 13G | AustralianSuper Pty Ltdnon-US institution | 8.3M | 5.7% | 2026-06-30 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 7.9M | 5.4% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 12.0M | 8.2% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 14 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding RMD at their latest 13F. JSON8 of the 30 tracked managers held RMD at their latest 13F, $421.1M in total at quarter-end prices. AQR Capital Management is the largest at $177.1M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 6 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 911K | $177.1M | 0.06% | +561K |
| Citadel Advisors | 2026-06-30 | 508K | $99.1M | 0.01% | +176K |
| Two Sigma Investments | 2026-06-30 | 411K | $80.1M | 0.06% | +99K |
| Millennium Management | 2026-06-30 | 205K | $39.9M | 0.01% | +62K |
| Bridgewater Associates | 2026-06-30 | 67K | $13.1M | 0.05% | +28K |
| Fisher Asset Management | 2026-06-30 | 53K | $10.2M | 0.00% | -2K |
| D. E. Shaw & Co. | 2026-06-30 | 6K | $1.2M | 0.00% | -5K |
| Renaissance Technologies | 2026-06-30 | 2K | $316K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q4 FY 2026 (quarter ended 2026-06-30) ResMed reported revenue of $1.46B, up 8.6% from the same quarter a year earlier, and net income of $383.4M. In FY 2026 it generated $1.81B of operating cash flow and spent $700.0M on buybacks and $349.7M on dividends. As of 2026-06-30, cash was $1.47B against $399.4M of debt.
- Cash
- $1.47B
- Debt
- $399.4M
- Equity
- $6.59B
- Total assets
- $8.97B
- Shares outstanding
- 144,252,306
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q4 FY 2026derived | 2026-06-30 | $1.46B | $383.4M | 26.2% | n/a |
| Q3 FY 2026 | 2026-03-31 | $1.43B | $398.7M | 27.9% | 2.74 |
| Q2 FY 2026 | 2025-12-31 | $1.42B | $392.6M | 27.6% | 2.68 |
| Q1 FY 2026 | 2025-09-30 | $1.34B | $348.5M | 26.1% | 2.37 |
| Q4 FY 2025derived | 2025-06-30 | $1.35B | $379.7M | 28.2% | n/a |
| Q3 FY 2025 | 2025-03-31 | $1.29B | $365.0M | 28.3% | 2.48 |
| Q2 FY 2025 | 2024-12-31 | $1.28B | $344.6M | 26.9% | 2.34 |
| Q1 FY 2025 | 2024-09-30 | $1.22B | $311.4M | 25.4% | 2.11 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $5.65B | $1.52B | $1.81B | $156.3M | $700.0M | $349.7M |
| FY 2025 | 2025-06-30 | $5.15B | $1.40B | $1.75B | $89.9M | $300.0M | $310.9M |
| FY 2024 | 2024-06-30 | $4.69B | $1.02B | $1.40B | $99.5M | $150.0M | $282.3M |
| FY 2023 | 2023-06-30 | $4.22B | $897.6M | $693.3M | $119.7M | $0 | $258.3M |
| FY 2022 | 2022-06-30 | $3.58B | $779.4M | $351.1M | $134.8M | $0 | $245.3M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-10 from the cover page.
What this page is
ResMed in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows ResMed (RMD), SEC CIK 943819, listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-10-23.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-29.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-23.JSON and CSV
- Company record
- EDGAR filing index for CIK 943819Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
- MPWRMonolithic Power Systems
- MRKMerck
- MRNAModerna
- MRSHMarsh & McLennan Companies
- MRVLMarvell Technology
- MSMorgan Stanley
- MSCIMSCI
- MSFTMicrosoft
- MSGSMadison Square Garden Sports
- MSIMotorola Solutions
- MSTRStrategy
- MTBM&T Bank
- MTCHMatch Group
- MTDMettler-Toledo International
- MTNVail Resorts
- MTSIMACOM Technology Solutions Holdings
Datasets
Frequently Asked Questions
How much of RMD is sold short?
11,920,328 shares were held short at the 2026-10-15 settlement, 12.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is RMD's daily short volume?
On 2026-11-02, 461,065 of the 587,135 RMD shares reported to FINRA were sold short, 78.5% of the day's reported volume. Short volume is a flow for one day, not a position.
Does RMD have fails to deliver?
The SEC's latest file shows 1 RMD shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are RMD insiders buying or selling?
Insiders at RMD reported 6 open-market sells worth $5.4M in the last 90 days and no open-market buys. Latest filing: Rider Michael J (Global General Counsel) on 2026-10-23.
Have RMD insiders filed to sell?
35 Form 144 notices on file for RMD worth $26.5M at the prices reported; 4 in the last 90 days worth $3.4M. Latest: Rider Michael J filed on 2026-10-23 to sell 400 shares ($102K) from 2026-10-23.
Who owns 5% or more of RMD?
3 holders report 5% or more of RMD in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 8.2% of the class (11,961,706 shares), filed 2026-04-29 for an event on 2026-03-31.
What did RMD report last quarter?
In Q4 FY 2026 (quarter ended 2026-06-30) ResMed reported revenue of $1.46B, up 8.6% from the same quarter a year earlier, and net income of $383.4M. In FY 2026 it generated $1.81B of operating cash flow and spent $700.0M on buybacks and $349.7M on dividends. As of 2026-06-30, cash was $1.47B against $399.4M of debt.
Which tracked 13F managers own RMD?
8 of the 30 tracked 13F managers held RMD shares at their latest filing, $421.1M in all. The largest: Cliff Asness's AQR Capital Management (911K shares, $177.1M), Ken Griffin's Citadel Advisors (508K shares, $99.1M), Two Sigma Investments (411K shares, $80.1M), Izzy Englander's Millennium Management (205K shares, $39.9M), Ray Dalio's Bridgewater Associates (67K shares, $13.1M), Ken Fisher's Fisher Asset Management (53K shares, $10.2M). The table above lists all 8.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.